<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Cystic Fibrosis on VitaminDWiki</title><link>/categories/cystic-fibrosis.html</link><description>Recent content in Cystic Fibrosis on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 18 Jan 2024 00:00:00 +0000</lastBuildDate><atom:link href="/categories/cystic-fibrosis/index.xml" rel="self" type="application/rss+xml"/><item><title>Cystic Fibrosis patients have low vitamin D (need different dosing) – meta-analysis</title><link>/posts/cystic-fibrosis-patients-have-low-vitamin-d-need-different-dosing-meta-analysis.html</link><pubDate>Thu, 18 Jan 2024 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-patients-have-low-vitamin-d-need-different-dosing-meta-analysis.html</guid><description>&lt;p>&lt;strong>CF patients should greatly benefit from 1 or more of the following:&lt;/strong>&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Gut-friendly vitamin D (more adsorbable)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Topical or buccal Vitamin D (bypass many poor Vitamin D genes)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Infrequent Vitamin D dosing (weekly, bi-weekly)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Addition of Magnesium (has been found to help CF)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Addition of Omega-3 (has been found to help CF)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Inhaled Vitamin D (bypass many poor Vitamin D genes)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Addition of probiotic or prebiotic (reduce gut inflammation and improve Vit. D absorption)&lt;/p></description></item><item><title>Cystic Fibrosis appears associated with poor Vitamin D genes (radioactive tracing)</title><link>/posts/cystic-fibrosis-appears-associated-with-poor-vitamin-d-genes-radioactive-tracing.html</link><pubDate>Tue, 23 May 2023 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-appears-associated-with-poor-vitamin-d-genes-radioactive-tracing.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#metabolism-and-pharmacokinetics-of-vitamin-d-in-patients-with-cystic-fibrosis">METABOLISM AND PHARMACOKINETICS OF VITAMIN D in PATIENTS with Cystic Fibrosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#any-of-4-poor-genescategoriesgenetics-marked-with-span-stylecolorf06red-starspan-can-cause-the-altered-vitami-d-metabolism-seen-in-this-study">Any of 4 poor &lt;a href="/categories/genetics">genes&lt;/a> (marked with &lt;span style="color:#F06;">red star&lt;/span>) can cause the altered Vitami D metabolism seen in this study&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="metabolism-and-pharmacokinetics-of-vitamin-d-in-patients-with-cystic-fibrosis">METABOLISM AND PHARMACOKINETICS OF VITAMIN D in PATIENTS with Cystic Fibrosis&lt;/h4>
&lt;p>J. of Steroid Biochemistry and Molecular Biology &lt;a href="https://doi.org/10.1016/j.jsbmb.2023.106332">https://doi.org/10.1016/j.jsbmb.2023.106332&lt;/a>&lt;/p>
&lt;p>lMackenzie C. Bergagnini-Kolev a 1 2, Simon Hsu b c 2, Moira L. Aitken d, Christopher H. Goss e f, Andrew N. Hoofnagle b g, Leila R. Zelnick b c, Dawn Lum b c, Cora M. Best b g 3, Kenneth E. Thummel a, Bryan R. Kestenbaum b c, Ian H. de Boer b c, Yvonne S. Lin a&lt;/p></description></item><item><title>Vitamin D non-responders may have one or more poor genes: GC, LIPC, CYP24A1, and PDE3B</title><link>/posts/vitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b.html</link><pubDate>Mon, 03 Oct 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#genetic-factors-help-explain-the-variable-responses-of-young-children-with-cystic-fibrosis-to-vitamin-d-supplements">Genetic factors help explain the variable responses of young children with cystic fibrosis to vitamin D supplements&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-related-studies-in-vitamindwiki">See related studies in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="genetic-factors-help-explain-the-variable-responses-of-young-children-with-cystic-fibrosis-to-vitamin-d-supplements">Genetic factors help explain the variable responses of young children with cystic fibrosis to vitamin D supplements&lt;/h4>
&lt;p>Clin Nutr ESPEN 2022 Oct;51:367-376. &lt;a href="https://doi.org/10.1016/j.clnesp.2022.07.018">doi: 10.1016/j.clnesp.2022.07.018&lt;/a>&lt;/p>
&lt;p>HuiChuan J Lai 1 , Jie Song 2 , Qiongshi Lu 3 , Sangita G Murali 4 , Manavalan Gajapathy 5 , Brandon M Wilk 5 , Donna M Brown 5 , Elizabeth A Worthey 5 , Philip M Farrell 6 , FIRST Study Group&lt;/p></description></item><item><title>Vitamin D energizes the innate and adaptive immune systems to fight lung inflammation</title><link>/posts/vitamin-d-energizes-the-innate-and-adaptive-immune-systems-to-fight-lung-inflammation.html</link><pubDate>Mon, 19 Sep 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-energizes-the-innate-and-adaptive-immune-systems-to-fight-lung-inflammation.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#recent-advances-in-vitamin-d-implications-in-chronic-respiratory-diseases">Recent advances in vitamin D implications in chronic respiratory diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="recent-advances-in-vitamin-d-implications-in-chronic-respiratory-diseases">Recent advances in vitamin D implications in chronic respiratory diseases&lt;/h4>
&lt;p>Respir Res. 2022 Sep 19;23(1):252. &lt;a href="doi:10.1186/s12931-022-02147-x">doi:10.1186/s12931-022-02147-x&lt;/a>&lt;/p>
&lt;p>Mellissa Gaudet 1 , Maria Plesa 1 , Andrea Mogas 1 , Nour Jalaleddine 2 , Qutayba Hamid 3 4 , Saba Al Heialy 5 6&lt;/p>
&lt;p>&lt;strong>PDF Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/toc-repiratory.jpg" alt="image" width="500">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/innate-adaptive-lung.jpg" alt="image" width="700">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/inflammation-lung.jpg" alt="image" width="700">
&lt;p>Chronic airway inflammatory and infectious respiratory diseases are the most common medical respiratory conditions, associated with significant morbidity and mortality. Vitamin D (1,25(OH)2D3) deficiency has been shown to be highly prevalent in patients with chronic airway inflammatory and infectious diseases, correlated with increased disease severity. It has been established that vitamin D modulates ongoing abnormal immune responses in chronic respiratory diseases and is shown to restrict bacterial and viral colonization into the lungs. On the contrary, other studies revealed controversy findings regarding vitamin D efficacy in respiratory diseases. This review aims to update the current evidence regarding the role of vitamin D in airway inflammation and in various respiratory diseases. A comprehensive search of the last five years of literature was conducted using MEDLINE and non-MEDLINE PubMed databases, Ovid MEDLINE, SCOPUS-Elsevier, and data from in vitro and in vivo experiments, including clinical studies. This review highlights the importance of understanding the full range of implications that vitamin D may have on lung inflammation, infection, and disease severity in the context of chronic respiratory diseases.&lt;/p></description></item><item><title>Cystic Fibrosis is associated with low Magnesium, supplementation would probably help -review 2016</title><link>/posts/cystic-fibrosis-is-associated-with-low-magnesium-supplementation-would-probably-help-review-2016.html</link><pubDate>Fri, 09 Sep 2022 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-is-associated-with-low-magnesium-supplementation-would-probably-help-review-2016.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#magnesium-in-cystic-fibrosis--systematic-review-of-the-literature">Magnesium in cystic fibrosis&amp;ndash;Systematic review of the literature&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="magnesium-in-cystic-fibrosis--systematic-review-of-the-literature">Magnesium in cystic fibrosis&amp;ndash;Systematic review of the literature&lt;/h4>
&lt;p>Pediatr Pulmonol. 2016 Feb;51(2):196-202 &lt;a href="https://doi.org/10.1002/ppul.23356">doi: 10.1002/ppul.23356&lt;/a>&lt;/p>
&lt;p>Maristella Santi 1 , Gregorio P Milani 2 , Giacomo D Simonetti 1 3 , Emilio F Fossali 2 , Mario G Bianchetti 1 , Sebastiano A G Lava 1 3&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/cf-mg-table.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/mg-deficiency.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/cf-mg-possible-benefits.jpg" alt="image" width="900">
&lt;p>Background: The metabolism of sodium, potassium, and chloride and the acid-base balance are sometimes altered in cystic fibrosis. Textbooks and reviews only marginally address the homeostasis of magnesium in cystic fibrosis.&lt;/p></description></item><item><title>Poor or no response to vitamin D was associated with poor genes (cystic fibrosis, 4 genes)</title><link>/posts/poor-or-no-response-to-vitamin-d-was-associated-with-poor-genes-cystic-fibrosis-4-genes.html</link><pubDate>Wed, 07 Sep 2022 00:00:00 +0000</pubDate><guid>/posts/poor-or-no-response-to-vitamin-d-was-associated-with-poor-genes-cystic-fibrosis-4-genes.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#genetic-factors-help-explain-the-variable-responses-of-young-children-with-cystic-fibrosis-to-vitamin-d-supplements">Genetic factors help explain the variable responses of young children with cystic fibrosis to vitamin D supplements&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#in-vitamindwiki-but-probably-not-considered-by-this-study">In VitaminDWiki, but probably not considered by this study&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="genetic-factors-help-explain-the-variable-responses-of-young-children-with-cystic-fibrosis-to-vitamin-d-supplements">Genetic factors help explain the variable responses of young children with cystic fibrosis to vitamin D supplements&lt;/h4>
&lt;p>Clinical Nutrition ESPEN &lt;a href="https://doi.org/10.1016/j.clnesp.2022.07.018">https://doi.org/10.1016/j.clnesp.2022.07.018&lt;/a>&lt;/p>
&lt;p>JieSongdQiongshiLudeSangita G.MuraliaManavalanGajapathyfBrandon M.WilkfDonna M.BrownfElizabeth A.WortheyfPhilip M.FarrellbcFIRST Study Group&lt;/p>
&lt;p>Background &amp;amp; aims&lt;/p>
&lt;p>Children with cystic fibrosis (CF) are susceptible to fat-soluble vitamin deficiencies unless supplemented, but even large doses of vitamin D may not prevent low 25-hydroxyvitamin D (25OHD) concentrations. The explanation for these vitamin D non-responders has been elusive. We utilized data from whole genome sequencing (WGS) to test the hypothesis that genetic variations predict responsiveness to vitamin D supplementation in a prospective cohort study of children with CF in the first 3 years of life.&lt;/p></description></item><item><title>Half of Cystic Fibrosis patients have low Magnesium levels</title><link>/posts/half-of-cystic-fibrosis-patients-have-low-magnesium-levels.html</link><pubDate>Mon, 25 Apr 2022 00:00:00 +0000</pubDate><guid>/posts/half-of-cystic-fibrosis-patients-have-low-magnesium-levels.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#magnesium-status-and-calciummagnesium-ratios-in-a-series-of-cystic-fibrosis-patients">Magnesium Status and Calcium/Magnesium Ratios in a Series of Cystic Fibrosis Patients&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#appears-that-cystic-fibrosiscategoriescystic-fibrosis-needs-vitamin-d-magnesium-vitamin-k2-etc">Appears that &lt;a href="/categories/cystic-fibrosis">Cystic Fibrosis&lt;/a> needs Vitamin D, Magnesium, Vitamin K2, etc.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="magnesium-status-and-calciummagnesium-ratios-in-a-series-of-cystic-fibrosis-patients">Magnesium Status and Calcium/Magnesium Ratios in a Series of Cystic Fibrosis Patients&lt;/h4>
&lt;p>Nutrients 2022, 14(9), 1793; &lt;a href="https://doi.org/10.3390/nu14091793">https://doi.org/10.3390/nu14091793&lt;/a> (registering DOI)&lt;/p>
&lt;p>by Marlene Fabiola Escobedo-Monge 1,*ORCID,Enrique Barrado 2,Joaquín Parodi-Román 3,María Antonieta Escobedo-Monge 4ORCID,Marianela Marcos-Temprano 5 andJosé Manuel Marugán-Miguelsanz 1,6&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/mg-vs-cf-years.jpg" alt="image" width="600">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/mg-cf.jpg" alt="image" width="600">
&lt;p>Magnesium (Mg) is an essential micronutrient that participates in various enzymatic reactions that regulate vital biological functions. The main aim was to assess the Mg status and its association with nutritional indicators in seventeen cystic fibrosis (CF) patients. The serum Mg and calcium (Ca) levels were determined using standardized methods and the dietary Mg intake by prospective 72 h dietary surveys.&lt;/p></description></item><item><title>Cystic Fibrosis vitamin D recommendations are not enough</title><link>/posts/cystic-fibrosis-vitamin-d-recommendations-are-not-enough.html</link><pubDate>Thu, 09 Dec 2021 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-vitamin-d-recommendations-are-not-enough.html</guid><description>&lt;h4 id="vitamin-d-status-in-pediatric-and-young-adult-cystic-fibrosis-patients-are-the-new-recommendations-effective">Vitamin D Status in Pediatric and Young Adult Cystic Fibrosis Patients. Are the New Recommendations Effective?&lt;/h4>
&lt;p>Nutrients 2021, 13(12), 4413; &lt;a href="https://doi.org/10.3390/nu13124413">https://doi.org/10.3390/nu13124413&lt;/a>&lt;/p>
&lt;p>by Carmen Mangas-Sánchez 1,María Garriga-García 2,María Juliana Serrano-Nieto 3,Ruth García-Romero 4,Marina Álvarez-Beltrán 5,Elena Crehuá-Gaudiza 6ORCID,Rosana Muñoz-Codoceo 7,Lucrecia Suárez-Cortina 2,Saioa Vicente-Santamaría 2,Cecilia Martínez-Costa 6,Juan José Díaz-Martin 1,*,Carlos Bousoño-García 1 andDavid González-Jiménez 1ORCID&lt;/p>
&lt;p>Introduction: In recent years, guidelines for vitamin D supplementation have been updated and prophylactic recommended doses have been increased in patients with cystic fibrosis (CF).&lt;/p></description></item><item><title>Cystic Fibrosis patients need different forms of Vitamin D</title><link>/posts/cystic-fibrosis-patients-need-different-forms-of-vitamin-d.html</link><pubDate>Wed, 24 Nov 2021 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-patients-need-different-forms-of-vitamin-d.html</guid><description>&lt;h4 id="a-clinicians-guide-to-vitamin-d-supplementation-for-patients-with-cystic-fibrosis">A Clinician&amp;rsquo;s guide to vitamin D supplementation for patients with cystic fibrosis&lt;/h4>
&lt;p>J Clin Transl Endocrinol . 2021 Nov 6;26:100273. &lt;a href="https://doi.org/10.1016/j.jcte.2021.100273.">doi: 10.1016/j.jcte.2021.100273.&lt;/a>&lt;/p>
&lt;p>Colleen Wood 1, Sana Hasan 2, Amy Darukhanavala 3, Vin Tangpricha 4&lt;/p>
&lt;p>Vitamin D deficiency is common in the general population, and even more so in patients with cystic fibrosis. Deficiency is exacerbated in cystic fibrosis patients because of a myriad of causes including malabsorption, decreased fat mass, reduced 25-hydroxylation of vitamin D, reduced exposure to sunlight, decreased vitamin D binding protein, and exposure to drugs that increase catabolism. In turn, vitamin D deficiency can contribute to poor bone health. Additionally, it may contribute to pulmonary decline in the form of worsening pulmonary function, increased colonization with pathogens, and increased pulmonary exacerbation. Because vitamin D deficiency is correlated with negative clinical effects in multiple organ systems of patients with cystic fibrosis, it is important to screen for and treat deficiency in these patients. The Cystic Fibrosis Foundation has issued guidelines for the treatment of vitamin D deficiency, targeting serum levels of 25-hydroxyvitamin D of at least 30 ng/ml. The guidelines offer age-specific escalating dose regimens depending on serum vitamin D levels, with monitoring at 12- week intervals after changing therapy. They address the literature on alternative vitamin D sources, such as UV lamps, ideal formulations (cholecalciferol in preference to ergocalciferol), and optimal vehicles of administration. Despite these detailed recommendations, most centers are still unable to achieve in-target serum vitamin D levels for many of their patients. Future research examining ideal treatment regimens to achieve serum targets and maximize clinical effects are needed. Moreover, it is unknown whether vitamin D sufficiency will be easier to achieve on new triple therapy cystic fibrosis drug combinations, and how these drugs will contribute to vitamin D-related clinical outcomes.&lt;/p></description></item><item><title>26 health factors increase the risk of COVID-19 – all are proxies for low vitamin D</title><link>/posts/26-health-factors-increase-the-risk-of-covid-19-all-are-proxies-for-low-vitamin-d.html</link><pubDate>Fri, 19 Feb 2021 00:00:00 +0000</pubDate><guid>/posts/26-health-factors-increase-the-risk-of-covid-19-all-are-proxies-for-low-vitamin-d.html</guid><description/></item><item><title>Cystic Fibrosis is safely treated by high-dose Vitamin D</title><link>/posts/cystic-fibrosis-is-safely-treated-by-high-dose-vitamin-d.html</link><pubDate>Mon, 25 Nov 2019 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-is-safely-treated-by-high-dose-vitamin-d.html</guid><description>&lt;h4 id="high-dose-cholecalciferol-supplementation-in-adults-with-cystic-fibrosis">High-dose Cholecalciferol Supplementation in Adults with Cystic Fibrosis.&lt;/h4>
&lt;p>Pharmacotherapy. 2019 Sep;39(9):874-880. &lt;a href="https://doi.org/10.1002/phar.2307">doi: 10.1002/phar.2307&lt;/a>&lt;/p>
&lt;p>Janzen KM1, Sakon C1, Lehman A1, Sommer B1, Brown C1,2.&lt;/p>
&lt;p>1 Indiana University Health, Indianapolis, Indiana.&lt;/p>
&lt;p>2 Indiana University School of Medicine, Indianapolis, Indiana&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>&lt;a href="/posts/cystic-fibrosis-probably-treated-by-vitamin-d-if-use-enough-of-the-right-type">Cystic Fibrosis probably treated by Vitamin D (if use enough of the right type ) – Oct 2019&lt;/a>&lt;/li>
&lt;/ul>
&lt;/div>
&lt;p>INTRODUCTION:&lt;/p>
&lt;p>Despite the availability of consensus guidelines for the treatment of vitamin D deficiency, prospective trials are lacking to examine alternative dosing strategies for adult patients with cystic fibrosis (CF) who do not meet therapeutic goals with standard regimens.&lt;/p></description></item><item><title>Respiratory Disease exacerbations (Asthma, CF, COPD) may be treated by Vitamin D</title><link>/posts/respiratory-disease-exacerbations-asthma-cf-copd-may-be-treated-by-vitamin-d.html</link><pubDate>Mon, 25 Nov 2019 00:00:00 +0000</pubDate><guid>/posts/respiratory-disease-exacerbations-asthma-cf-copd-may-be-treated-by-vitamin-d.html</guid><description/></item><item><title>Cystic Fibrosis and Vitamin D review with 2012 Guidelines</title><link>/posts/cystic-fibrosis-and-vitamin-d-review-with-2012-guidelines.html</link><pubDate>Sat, 09 Nov 2019 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-and-vitamin-d-review-with-2012-guidelines.html</guid><description/></item><item><title>Cystic Fibrosis probably treated by Vitamin D (if use enough of the right type )</title><link>/posts/cystic-fibrosis-probably-treated-by-vitamin-d-if-use-enough-of-the-right-type.html</link><pubDate>Wed, 06 Nov 2019 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-probably-treated-by-vitamin-d-if-use-enough-of-the-right-type.html</guid><description/></item><item><title>Cystic Fibrosis guidelines for Australia include Vitamin D</title><link>/posts/cystic-fibrosis-guidelines-for-australia-include-vitamin-d.html</link><pubDate>Tue, 03 Sep 2019 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-guidelines-for-australia-include-vitamin-d.html</guid><description/></item><item><title>Cystic Fibrosis helped in many ways by Vitamin K</title><link>/posts/cystic-fibrosis-helped-in-many-ways-by-vitamin-k.html</link><pubDate>Mon, 29 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-helped-in-many-ways-by-vitamin-k.html</guid><description>&lt;h4 id="span-stylecolor00fupdate---rct-to-be-completed-dec-2021span">&lt;span style="color:#00F;">Update - RCT to be completed Dec 2021&lt;/span>&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.clinicaltrials.gov/ct2/show/NCT04496921?sfpd_s=07%2F21%2F2020&amp;amp;sfpd_d=14">Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic Fibrosis (VITK-FK)&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Group A: 2mg, every day for 6 months&lt;/p>
&lt;p>Group B: 7mg, twice a week for 6 months&lt;/p>
&lt;p>Apparently using phylloquinone = K1&lt;/p>
&lt;p>Wonder about K2 and D3&lt;/p>
&lt;hr>
&lt;h4 id="vitamin-k-and-cystic-fibrosis-a-gordian-knot-that-deserves-our-attention">Vitamin K and cystic fibrosis: A gordian knot that deserves our attention.&lt;/h4>
&lt;p>Respir Med. 2019 Jul 6;155:36-42. &lt;a href="https://doi.org/10.1016/j.rmed.2019.07.005">doi: 10.1016/j.rmed.2019.07.005&lt;/a>&lt;/p>
&lt;p>Hatziparasides G1, Loukou I2, Moustaki M2, Douros K3.&lt;/p></description></item><item><title>Cystic Fibrosis not helped by 50,000 IU of Vitamin D taken twice a month – RCT</title><link>/posts/cystic-fibrosis-not-helped-by-50000-iu-of-vitamin-d-taken-twice-a-month-rct.html</link><pubDate>Sat, 23 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-not-helped-by-50000-iu-of-vitamin-d-taken-twice-a-month-rct.html</guid><description>&lt;p>BACKGROUND:&lt;/p>
&lt;p>Patients with cystic fibrosis (CF) have increased risk of vitamin D deficiency owing to fat malabsorption and other factors. Vitamin D deficiency has been associated with increased risk of pulmonary exacerbations of CF.&lt;/p>
&lt;p>OBJECTIVES:&lt;/p>
&lt;p>The primary objective of this study was to examine the impact of a single high-dose bolus of vitamin D3 followed by maintenance treatment given to adults with CF during an acute pulmonary exacerbation on future recurrence of pulmonary exacerbations.&lt;/p></description></item><item><title>Vitamin D dose size should increase with body weight (Cystic Fibrosis in this case)</title><link>/posts/vitamin-d-dose-size-should-increase-with-body-weight-cystic-fibrosis-in-this-case.html</link><pubDate>Sun, 18 Nov 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-dose-size-should-increase-with-body-weight-cystic-fibrosis-in-this-case.html</guid><description/></item><item><title>Vitamin D has been recommended for Cystic Fibrosis – a small dose helps a little</title><link>/posts/vitamin-d-has-been-recommended-for-cystic-fibrosis-a-small-dose-helps-a-little.html</link><pubDate>Sat, 11 Aug 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-has-been-recommended-for-cystic-fibrosis-a-small-dose-helps-a-little.html</guid><description>&lt;h4 id="increasing-vitamin-d-serum-levels-is-associated-with-reduced-pulmonary-exacerbations-in-patients-with-cystic-fibrosis">Increasing Vitamin D Serum Levels Is Associated with Reduced Pulmonary Exacerbations in Patients with Cystic Fibrosis.&lt;/h4>
&lt;p>J Pediatr Gastroenterol Nutr. 2018 Aug 8. &lt;a href="https://doi.org/10.1097/MPG.0000000000002126.">doi: 10.1097/MPG.0000000000002126.&lt;/a>&lt;/p>
&lt;p>Abu-Fraiha Y1, Elyashar-Earon H, Shoseyov D, Cohen-Cymberknoh M, Armoni S, Kerem E, Wilschanski M.&lt;/p>
&lt;p>CF Center, Hadassah-University Medical Center, Jerusalem, Israel.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>Abstract fails to mention Vitamin D dose size&lt;/p>
&lt;p>Abstract was not on Sci-Hub Aug 11, 2018&lt;/p>
&lt;p>&lt;a href="https://journals.lww.com/jpgn/Abstract/publishahead/Increasing_Vitamin_D_Serum_Levels_Is_Associated.96707.aspx%20">Publisher want $49 for the PDF&lt;/a>&lt;/p>
&lt;p>Must have been a small dose as vitamin D levels were raised from 21 ng to only 25 ng&lt;/p></description></item><item><title>Many Ashkenazi Jewish diseases associated with low vitamin D or poor Vit D genes</title><link>/posts/many-ashkenazi-jewish-diseases-associated-with-low-vitamin-d-or-poor-vit-d-genes.html</link><pubDate>Mon, 23 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/many-ashkenazi-jewish-diseases-associated-with-low-vitamin-d-or-poor-vit-d-genes.html</guid><description/></item><item><title>Low vitamin D while Cystic Fibrosis is active</title><link>/posts/low-vitamin-d-while-cystic-fibrosis-is-active.html</link><pubDate>Thu, 19 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-while-cystic-fibrosis-is-active.html</guid><description>&lt;h4 id="vitamin-d-status-correlates-with-the-markers-of-cystic-fibrosis-related-pulmonary-disease">Vitamin D Status Correlates With The Markers of Cystic Fibrosis-Related Pulmonary Disease&lt;/h4>
&lt;p>Pediatrics &amp;amp; Neonatology &lt;a href="https://doi.org/10.1016/j.pedneo.2018.07.001">https://doi.org/10.1016/j.pedneo.2018.07.001&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>| | |
| &amp;mdash; | &amp;mdash; |
| Vitamin D level | Cystic Fibrosis periods |
| 16 ng | exacerbations, |
| 24 ng | colonization |
| 49 ng | routine follow-up |&lt;/strong>&lt;/p>
&lt;hr>
&lt;p>&lt;strong>Speculations by founder of VitaminDWiki&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>CF patients should use a form of vitamin D which deals with associated poor gut function&lt;/p></description></item><item><title>If vitamin D levels are less than 40 ng some children get cystic fibrosis</title><link>/posts/if-vitamin-d-levels-are-less-than-40-ng-some-children-get-cystic-fibrosis.html</link><pubDate>Mon, 09 Apr 2018 00:00:00 +0000</pubDate><guid>/posts/if-vitamin-d-levels-are-less-than-40-ng-some-children-get-cystic-fibrosis.html</guid><description/></item><item><title>Powder-based Vitamin D may be gut-friendly (Cystic Fibrosis) – RCT</title><link>/posts/powder-based-vitamin-d-may-be-gut-friendly-cystic-fibrosis-rct.html</link><pubDate>Sun, 04 Feb 2018 00:00:00 +0000</pubDate><guid>/posts/powder-based-vitamin-d-may-be-gut-friendly-cystic-fibrosis-rct.html</guid><description/></item><item><title>Cystic Fibrosis got some benefit from 50,000 IU of vitamin D weekly (need gut-friendly form)</title><link>/posts/cystic-fibrosis-got-some-benefit-from-50000-iu-of-vitamin-d-weekly-need-gut-friendly-form.html</link><pubDate>Sat, 03 Feb 2018 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-got-some-benefit-from-50000-iu-of-vitamin-d-weekly-need-gut-friendly-form.html</guid><description/></item><item><title>Vitamin D changed microbiota in gut and airway, might reduce cystic fibrosis – RCT</title><link>/posts/vitamin-d-changed-microbiota-in-gut-and-airway-might-reduce-cystic-fibrosis-rct.html</link><pubDate>Mon, 27 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-changed-microbiota-in-gut-and-airway-might-reduce-cystic-fibrosis-rct.html</guid><description/></item><item><title>Cystic Fibrosis may be related to low Vitamin D</title><link>/posts/cystic-fibrosis-may-be-related-to-low-vitamin-d.html</link><pubDate>Thu, 05 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-may-be-related-to-low-vitamin-d.html</guid><description>&lt;h4 id="role-of-vitamin-d-in-cystic-fibrosis-and-non-cystic-fibrosis-bronchiectasis">Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis.&lt;/h4>
&lt;p>World J Clin Pediatr. 2017 Aug 8;6(3):132-142. &lt;a href="https://doi.org/10.5409/wjcp.v6.i3.132.">doi: 10.5409/wjcp.v6.i3.132.&lt;/a> eCollection 2017 Aug 8.&lt;/p>
&lt;p>Moustaki M 1, Loukou I 1, Priftis KN 1, Douros K 1.&lt;/p>
&lt;p>1 Maria Moustaki, Ioanna Loukou, Cystic Fibrosis Unit, &amp;ldquo;Aghia Sophia&amp;rdquo; Children&amp;rsquo;s Hospital, 11527 Athens, Greece.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/cystic-fibrosis-exacerbation-reduced-by-vitamin-d-250000-iu-rct">Cystic Fibrosis exacerbation reduced by Vitamin D (250,000 IU) – RCT May 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/cystic-fibrosis-treatment-by-vitamin-d-improved-quality-of-life-and-breathing-8200-iu-daily-rct">Cystic fibrosis treatment by vitamin D improved quality of life and breathing (8200 IU daily)– RCT Dec 2016&lt;/a>&lt;/p></description></item><item><title>Cystic Fibrosis RCT to use 250,000 IU of vitamin D</title><link>/posts/cystic-fibrosis-rct-to-use-250000-iu-of-vitamin-d.html</link><pubDate>Sat, 20 May 2017 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-rct-to-use-250000-iu-of-vitamin-d.html</guid><description>&lt;h4 id="the-vitamin-d-for-enhancing-the-immune-system-in-cystic-fibrosis-disc-trial-rationale-and-design-of-a-multi-center-double-blind-placebo-controlled-trial-of-high-dose-bolus-administration-of-vitamin-d3-during-acute-pulmonary-exacerbation-of-cystic-fibrosis">The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis&lt;/h4>
&lt;p>Contemporary Clinical Trials Communications, Volume 6, June 2017, Pages 39–45, &lt;a href="https://doi.org/10.1016/j.conctc.2017.02.010">https://doi.org/10.1016/j.conctc.2017.02.010&lt;/a>&lt;/p>
&lt;p>Vin Tangpricha a, b, c, , &lt;a href="mailto:vin.tangpricha@emory.edu">vin.tangpricha@emory.edu&lt;/a>, Ellen M. Smith c, Jose Binongo d, Suzanne E. Judd e, Thomas R. Ziegler a, b, c, Seth Walker f, Rabindra Tirouvanziam g, Susu M. Zughaier h, Moon Jeong Lee a, b, Supavit Chesdachaia, b,&lt;/p></description></item><item><title>Cystic Fibrosis exacerbation reduced by Vitamin D (250,000 IU) – RCT</title><link>/posts/cystic-fibrosis-exacerbation-reduced-by-vitamin-d-250000-iu-rct.html</link><pubDate>Sat, 22 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-exacerbation-reduced-by-vitamin-d-250000-iu-rct.html</guid><description>&lt;h4 id="plasma-metabolomics-in-adults-with-cystic-fibrosis-during-a-pulmonary-exacerbation-a-pilot-randomized-study-of-high-dose-vitamin-d3-administration">Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administration.&lt;/h4>
&lt;p>Metabolism. 2017 May;70:31-41. &lt;a href="https://doi.org/10.1016/j.metabol.2017.02.006.">doi: 10.1016/j.metabol.2017.02.006.&lt;/a> Epub 2017 Feb 11.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/cystic-fibrosis-treatment-by-vitamin-d-improved-quality-of-life-and-breathing-8200-iu-daily-rct">Cystic fibrosis treatment by vitamin D improved quality of life and breathing (8200 IU daily)– RCT Dec 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/cystic-fibrosis-problems-cut-in-half-by-omega-3-rct">Cystic fibrosis problems cut in half by Omega-3 – RCT June 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/cystic-fibrosis-foundation-recommends-vitamin-d-dose-patients-are-taking-even-more">Cystic Fibrosis Foundation recommends vitamin D dose, patients are taking even more – March 2015&lt;/a>&lt;/p></description></item><item><title>Vitamin D in respiratory diseases – Spring 2017</title><link>/posts/vitamin-d-in-respiratory-diseases-spring-2017.html</link><pubDate>Sun, 09 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-in-respiratory-diseases-spring-2017.html</guid><description/></item><item><title>Cystic fibrosis treatment by vitamin D improved quality of life and breathing (8200 IU daily)– RCT</title><link>/posts/cystic-fibrosis-treatment-by-vitamin-d-improved-quality-of-life-and-breathing-8200-iu-daily-rct.html</link><pubDate>Mon, 19 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-treatment-by-vitamin-d-improved-quality-of-life-and-breathing-8200-iu-daily-rct.html</guid><description>&lt;h4 id="see-also-web">See also Web&lt;/h4>
&lt;ul>
&lt;li>&lt;a href="https://cysticfibrosisnewstoday.com/2016/12/19/high-levels-vitamin-d-supplements-associated-improved-lung-function-cf-patients/">This study was reported at CFNewsToday&lt;/a>&lt;/li>
&lt;/ul></description></item><item><title>Lungs with cystic fibrosis fail to activate vitamin D (poor CYP27B)</title><link>/posts/lungs-with-cystic-fibrosis-fail-to-activate-vitamin-d-poor-cyp27b.html</link><pubDate>Sat, 13 Feb 2016 00:00:00 +0000</pubDate><guid>/posts/lungs-with-cystic-fibrosis-fail-to-activate-vitamin-d-poor-cyp27b.html</guid><description>&lt;h4 id="cystic-fibrosis-bronchial-epithelial-cells-have-impaired-ability-to-activate-vitamin-d">Cystic fibrosis bronchial epithelial cells have impaired ability to activate Vitamin D.&lt;/h4>
&lt;p>Acta Paediatr. 2016 Feb 10. Doi: 10.1111/apa.13361. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Pincikova T1,2,3, Svedin E3, Domsgen E3, Flodström-Tullberg M3, Hjelte L1,2.&lt;/p>
&lt;ul>
&lt;li>
&lt;p>1 Stockholm CF Center, Karolinska University Hospital Huddinge, Stockholm, Sweden.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>2 Division of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>3 Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.&lt;/p></description></item><item><title>Cystic fibrosis problems cut in half by Omega-3 – RCT</title><link>/posts/cystic-fibrosis-problems-cut-in-half-by-omega-3-rct.html</link><pubDate>Sun, 16 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-problems-cut-in-half-by-omega-3-rct.html</guid><description>&lt;h4 id="benefits-of-long-term-supplementation-with-omega-3-polyunsaturated-fatty-acids-in-cystic-fibrosis">Benefits of long-term supplementation with omega-3 polyunsaturated fatty acids in cystic fibrosis&lt;/h4>
&lt;p>Journal of Cystic Fibrosis, Volume 14, Supplement 1, June 2015, Pages S52&lt;/p>
&lt;p>Abstracts of the 38th European Cystic Fibrosis Conference. Oral Presentation ePS05.9&lt;/p>
&lt;p>L. Hanssensa, I. Thiébaulta, N. Lefevrea, A. Malfrootb, V. Gaspara, C. Knoopc, J. Duchateaud, G. Casimira&lt;/p>
&lt;p>Clinical symptoms and lung function of CF may be influenced by correcting essential fatty acids (EFA) deficiency. Nevertheless, the value of EFA supplementation in CF remains controversial.&lt;/p></description></item><item><title>50,000 IU of vitamin D weekly (D3 or D2) got two thirds of cystic fibrosis patients to 30 nanograms – RCT</title><link>/posts/50000-iu-of-vitamin-d-weekly-d3-or-d2-got-two-thirds-of-cystic-fibrosis-patients-to-30-nanograms-rct.html</link><pubDate>Tue, 28 Jul 2015 00:00:00 +0000</pubDate><guid>/posts/50000-iu-of-vitamin-d-weekly-d3-or-d2-got-two-thirds-of-cystic-fibrosis-patients-to-30-nanograms-rct.html</guid><description>&lt;h4 id="a-randomized-controlled-trial-of-vitamin-d-replacement-strategies-in-pediatric-cf-patients">A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.&lt;/h4>
&lt;p>J Cyst Fibros. 2015 Jul 23. pii: S1569-1993(15)00166-6. &lt;a href="https://doi.org/10.1016/j.jcf.2015.07.004.">doi: 10.1016/j.jcf.2015.07.004.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Simoneau T1, Sawicki GS2, Milliren CE3, Feldman HA3, Gordon CM4.&lt;/p>
&lt;p>1Boston Children&amp;rsquo;s Hospital, Division of Respiratory Diseases, Harvard Medical School, 300 Longwood Ave, Boston, MA, United States. Electronic address: &lt;a href="mailto:tsimoneau@connecticutchildrens.org">tsimoneau@connecticutchildrens.org&lt;/a>.&lt;/p>
&lt;p>2Boston Children&amp;rsquo;s Hospital, Division of Respiratory Diseases, Harvard Medical School, 300 Longwood Ave, Boston, MA, United States.&lt;/p></description></item><item><title>Single dose (up to 60,000 IU) vitamin D raised levels in 87 percent of Cystic fibrosis patients – RCT</title><link>/posts/single-dose-up-to-60000-iu-vitamin-d-raised-levels-in-87-percent-of-cystic-fibrosis-patients-rct.html</link><pubDate>Tue, 09 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/single-dose-up-to-60000-iu-vitamin-d-raised-levels-in-87-percent-of-cystic-fibrosis-patients-rct.html</guid><description>&lt;h4 id="single-high-dose-oral-vitamin-d3-stoss-therapy--a-solution-to-vitamin-d-deficiency-in-children-with-cystic-fibrosis">Single high-dose oral vitamin D3 (stoss) therapy&amp;ndash;a solution to vitamin D deficiency in children with cystic fibrosis?&lt;/h4>
&lt;p>J Cyst Fibros. 2013 Mar;12(2):177-82. &lt;a href="https://doi.org/10.1016/j.jcf.2012.08.007.">doi: 10.1016/j.jcf.2012.08.007.&lt;/a> Epub 2012 Sep 19.&lt;/p>
&lt;p>Shepherd D1, Belessis Y2, Katz T2, Morton J2, Field P2, Jaffe A2.&lt;/p>
&lt;p>OBJECTIVES:&lt;/p>
&lt;p>To determine the safety and efficacy of stoss therapy on vitamin D levels over a 12 month period in children with cystic fibrosis and vitamin D deficiency (&amp;lt;75 nmol/L).&lt;/p>
&lt;p>STUDY DESIGN:&lt;/p></description></item><item><title>Cystic Fibrosis Foundation recommends vitamin D dose, patients are taking even more</title><link>/posts/cystic-fibrosis-foundation-recommends-vitamin-d-dose-patients-are-taking-even-more.html</link><pubDate>Tue, 17 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-foundation-recommends-vitamin-d-dose-patients-are-taking-even-more.html</guid><description>&lt;h4 id="vitamin-d-deficiency-in-pediatric-patients-with-cystic-fibrosis-associated-risk-factors-in-the-northern-united-states">Vitamin d deficiency in pediatric patients with cystic fibrosis: associated risk factors in the northern United States.&lt;/h4>
&lt;p>South Med J. 2015 Mar;108(3):164-9. &lt;a href="https://doi.org/10.14423/SMJ.0000000000000254.">doi: 10.14423/SMJ.0000000000000254.&lt;/a>&lt;/p>
&lt;p>Lansing AH1, McDonald C1, Patel RA1, Meihls S1, Crowell K1, Chatfield B1, Pohl JF1.&lt;/p>
&lt;p>Departments of Psychology, Pediatric Pulmonology, and Pediatric Gastroenterology, Primary Children&amp;rsquo;s Hospital, U. of Utah School of Medicine, Salt Lake City.&lt;/p>
&lt;p>OBJECTIVES:&lt;/p>
&lt;p>Cystic fibrosis (CF) is associated with vitamin D deficiency, which can lead to adverse effects including recurrent pulmonary infections and osteoporosis. We longitudinally investigated calcifediol or 25-hydroxyvitamin D (25(OH)D) levels for our pediatric patients with CF based on the time of year as well as vitamin D supplementation dosing ranges for these patients at our CF center.&lt;/p></description></item><item><title>Cystic Fibrosis</title><link>/posts/cystic-fibrosis.html</link><pubDate>Fri, 16 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis.html</guid><description>&lt;ul>
&lt;li>
&lt;p>Cystic fibrosis (CF) is a genetic disorder that affects the lungs, pancreas, and other organs, leading to severe respiratory and digestive problems.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>162,428 people are living with CF around the world.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>105,352 (65%) have been diagnosed&lt;/p>
&lt;/li>
&lt;li>
&lt;p>57,076 individuals undiagnosed (Summary by Perplexity AI - March 2024)&lt;/p>
&lt;/li>
&lt;/ul>
&lt;hr>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#oral-vitamin-d-helps-cystic-fibrosis---meta-analysis-jan-2024">Oral vitamin D helps cystic fibrosis - meta-analysis Jan 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cf-treated-by-vitamins-d--a-c-e-and-zinc-omega-3-dha-garlic-ginseng-and-curcumin---mercola-may-2024">CF treated by Vitamins D, A, C, E, and zinc, omega-3 (DHA), garlic, ginseng and curcumin - Mercola May 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cystic-fibrosis-treatment-trikafta-costs-300000year---march-2024">Cystic Fibrosis treatment Trikafta costs $300,000/year - March 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#google-scholar-had-371-studies-with-cf-and-vitamin-d-in-their-title-as-of-march-2025httpsscholargooglecomscholarhlenas_sdt02c48qallintitle3a22vitamind2222cysticfibrosis22btng">Google Scholar had &lt;a href="https://scholar.google.com/scholar?hl=en&amp;amp;as_sdt=0%2C48&amp;amp;q=allintitle%3A+%22vitamin+d%22+%22cystic+fibrosis%22&amp;amp;btnG=">371 studies with CF and Vitamin D in their title as of March 2025&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-wikipediahttpsenwikipediaorgwikicystic_fibrosis">See also &lt;a href="https://en.wikipedia.org/wiki/Cystic_fibrosis">WikiPedia&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#uk-cystic-fibrosis-recommendations-to-be-released-in-2017">UK Cystic Fibrosis recommendations to be released in 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#average-annual-cost-of-cf--16000--march-2013">Average annual cost of CF = $16,000 (March 2013)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#role-of-vitamin-d-on-gut-microbiota-in-cystic-fibrosis---2018">Role of vitamin D on gut microbiota in cystic fibrosis - 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cf-results-in-pancreatic-insufficiency-induced-malabsorption---which-reduces-the-response-to-standard-vitamin-d---jan-2021">CF results in pancreatic insufficiency-induced malabsorption - which reduces the response to standard Vitamin D - Jan 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="oral-vitamin-d-helps-cystic-fibrosis---meta-analysis-jan-2024">Oral vitamin D helps cystic fibrosis - meta-analysis Jan 2024&lt;/h4>
&lt;p>&lt;strong>Vitamin D deficiency in patients with cystic fibrosis: a systematic review and meta-analysis&lt;/strong>&lt;/p></description></item><item><title>New Vitamin D Guidelines for Cystic Fibrosis Patients</title><link>/posts/new-vitamin-d-guidelines-for-cystic-fibrosis-patients.html</link><pubDate>Sun, 19 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/new-vitamin-d-guidelines-for-cystic-fibrosis-patients.html</guid><description>&lt;p>A copy of a blog post at &lt;a href="http://www.ourcfmattershawaii.com/">http://www.ourcfmattershawaii.com/&lt;/a>&lt;/p>
&lt;p>Hi all,&lt;/p>
&lt;p>As a result of the natural effects that cystic fibrosis has on the body, with regard to lung infections and the inability of cystics to absorb certain nutrients, those with CF typically carry insufficient levels of vitamin D. Earlier this year, the U.S. Cystic Fibrosis Foundation (CFF) updated their recommended guidelines of vitamin D intake and screening, which emphasizes the prevention of this vitamin’s deficiency in patients. This update, together with causes of low vitamin D levels in cystics, is discussed in today&amp;rsquo;s posting.&lt;/p></description></item><item><title>3800 IU of vitamin D is not enough for most children with cystic fibrosis</title><link>/posts/3800-iu-of-vitamin-d-is-not-enough-for-most-children-with-cystic-fibrosis.html</link><pubDate>Tue, 07 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/3800-iu-of-vitamin-d-is-not-enough-for-most-children-with-cystic-fibrosis.html</guid><description/></item><item><title>Cystic fibrosis helped with single dose of 250,000 IU of vitamin D – RCT</title><link>/posts/cystic-fibrosis-helped-with-single-dose-of-250000-iu-of-vitamin-d-rct.html</link><pubDate>Sun, 29 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-helped-with-single-dose-of-250000-iu-of-vitamin-d-rct.html</guid><description/></item><item><title>Death due to cystic fibrosis reduced about 4X due to 250000 IU of vitamin D – RCT</title><link>/posts/death-due-to-cystic-fibrosis-reduced-about-4x-due-to-250000-iu-of-vitamin-d-rct.html</link><pubDate>Sun, 29 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/death-due-to-cystic-fibrosis-reduced-about-4x-due-to-250000-iu-of-vitamin-d-rct.html</guid><description/></item><item><title>Vitamin D and the Lung – professional book 2012</title><link>/posts/vitamin-d-and-the-lung-professional-book-2012.html</link><pubDate>Sun, 27 May 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-the-lung-professional-book-2012.html</guid><description/></item><item><title>Cystic fibrosis associated with low vitamin D</title><link>/posts/cystic-fibrosis-associated-with-low-vitamin-d.html</link><pubDate>Sat, 28 Apr 2012 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-associated-with-low-vitamin-d.html</guid><description/></item><item><title>Cystic fibrosis not statistically helped by 1600 IU of vitamin D – Cochrane Review 2012</title><link>/posts/cystic-fibrosis-not-statistically-helped-by-1600-iu-of-vitamin-d-cochrane-review-2012.html</link><pubDate>Mon, 23 Jan 2012 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-not-statistically-helped-by-1600-iu-of-vitamin-d-cochrane-review-2012.html</guid><description/></item><item><title>Might use Vitamin D for cystic fibrosis and topically on skin</title><link>/posts/might-use-vitamin-d-for-cystic-fibrosis-and-topically-on-skin.html</link><pubDate>Mon, 20 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/might-use-vitamin-d-for-cystic-fibrosis-and-topically-on-skin.html</guid><description>&lt;p> &lt;/p>
&lt;p>&lt;a href="http://www.sciencedaily.com/releases/2011/06/110617185105.htm?utm_source=feedburner&amp;amp;utm_medium=feed&amp;amp;utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29&amp;amp;utm_content=Google+Reader">(June 18, 2011) &lt;/a>— Laboratory-grown gingival cells treated with vitamin D boosted their production of an endogenous antibiotic, and killed more bacteria than untreated cells, according to a paper in the June 2011 issue of the journal Infection and Immunity. The research suggests that vitamin D can help protect the gums from bacterial infections that lead to gingivitis and periodontitis. Periodontitis affects up to 50 percent of the US population, is a major cause of tooth loss, and can also contribute to heart disease. Most Americans are deficient in vitamin D.&lt;/p></description></item><item><title>People with Cystic Fibrosis should have more than 35 ng of vitamin D</title><link>/posts/people-with-cystic-fibrosis-should-have-more-than-35-ng-of-vitamin-d.html</link><pubDate>Wed, 30 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/people-with-cystic-fibrosis-should-have-more-than-35-ng-of-vitamin-d.html</guid><description>&lt;h1 id="appropriate-goal-level-for-25-hydroxyvitamin-d-in-cystic-fibrosis">Appropriate Goal Level for 25-Hydroxyvitamin D in Cystic Fibrosis.&lt;/h1>
&lt;p>Chest. 2011 Mar 10.&lt;/p>
&lt;p>West NE, Lechtzin N, Merlo CA, Turowski JB, Davis ME, Ramsay MZ, Watts SL, Stenner SP, Boyle MP.&lt;/p>
&lt;p>Johns Hopkins University, Department of Medicine, Division of Pulmonary and Critical Care Medicine. &lt;a href="mailto:nwest5@jhmi.edu">nwest5@jhmi.edu&lt;/a>.&lt;/p>
&lt;p>BACKGROUND: Vitamin D deficiency is common in Cystic Fibrosis (CF), and guidelines recommend 25-hydroxyvitamin D (25OHD) levels ?30ng/ml. This threshold was selected because parathyroid hormone (PTH) rises in healthy individuals when 25OHD falls below 30ng/ml. PTH levels &amp;gt;50pg/ml are associated with an increased risk of bone loss. However, the relationship between 25OHD and PTH has not been studied in CF. We sought to determine the appropriate goal 25OHD level in CF by identifying the level below which the risk of PTH &amp;gt;50 begins to increase.&lt;/p></description></item><item><title>Cystic Fibrosis - vitamin D level in blood varies with UV</title><link>/posts/cystic-fibrosis-vitamin-d-level-in-blood-varies-with-uv.html</link><pubDate>Thu, 20 Jan 2011 00:00:00 +0000</pubDate><guid>/posts/cystic-fibrosis-vitamin-d-level-in-blood-varies-with-uv.html</guid><description>&lt;h4 id="sunlight-is-an-important-determinant-of-vitamin-d-serum-concentrations-in-cystic-fibrosis">Sunlight is an important determinant of vitamin D serum concentrations in cystic fibrosis&lt;/h4>
&lt;p>Eur J Clin Nutr. 2011 Jan 19. doi:10.1038/ejcn.2010.280&lt;/p>
&lt;p>Robberecht E, Vandewalle S, Wehlou C, Kaufman JM, De Schepper J.&lt;/p>
&lt;p>CF Centre Ghent University Hospital, Ghent, Belgium.&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/sunlight-is-an-important-determinant-of-vitamin-d-.pdf">Download the PDF from Research Gate via VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Background/Objectives:The increase of bone disease in adult cystic fibrosis (CF) patients is partly attributed to inadequate serum concentrations of 25-OH cholecalciferol (25 (OH) D) blamed on fat malabsorption. Based on physiological, clinical and biochemical observations this pathogenesis is debatable. The objective was to ascertain the relative importance of different 25 (OH) D sources.&lt;/p></description></item><item><title>Increased vitamin D supplementation decreased cystic fibrosis</title><link>/posts/increased-vitamin-d-supplementation-decreased-cystic-fibrosis.html</link><pubDate>Tue, 05 Oct 2010 00:00:00 +0000</pubDate><guid>/posts/increased-vitamin-d-supplementation-decreased-cystic-fibrosis.html</guid><description>&lt;h4 id="inverse-relation-between-vitamin-d-and-serum-total-immunoglobulin-g-in-the-scandinavian-cystic-fibrosis-nutritional-study">Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study.&lt;/h4>
&lt;p>by: T. Pincikova, K. Nilsson, I. E. Moen, F. Karpati, G. Fluge, A. Hollsing, P. K. Knudsen, A. Lindblad, L. Mared, T. Pressler, L. Hjelte&lt;/p>
&lt;p>European journal of clinical nutrition, Vol. aop, No. current. (22 September 2010)&lt;/p>
&lt;p>Background/Objectives:The hallmark of cystic fibrosis (CF) is chronic lung inflammation. The severity of lung disease is closely correlated with immunoglobulin G (IgG) levels. Beyond its contribution to the bone health, the importance of vitamin D has not been fully recognized owing to the lack of human studies providing evidence of its benefit. In the context of the recently described immunomodulatory functions of vitamin D, we aimed to assess the relationship between vitamin D and IgG levels.&lt;/p></description></item><item><title>Vitamin D deficiency in cystic fibrosis</title><link>/posts/vitamin-d-deficiency-in-cystic-fibrosis.html</link><pubDate>Mon, 30 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-in-cystic-fibrosis.html</guid><description>&lt;p>Int J Endocrinol. 2010;2010:218691. Epub 2010 Jan 28.&lt;/p>
&lt;p>Hall WB, Sparks AA, Aris RM.&lt;/p>
&lt;p>Division of Pulmonary and Critical Care Medicine and the School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.&lt;/p>
&lt;p>Cystic Fibrosis is the most common inherited genetic respiratory disorder in the Western World. Hypovitaminosis D is almost universal in CF patients, likely due to a combination of inadequate absorption, impaired metabolism, and lack of sun exposure. Inadequate levels are associated with the high prevalence of bone disease or osteoporosis in CF patients, which is associated with increased morbidity including fractures, kyphosis, and worsening pulmonary status. Treatment goals include regular monitoring 25 hydroxyvitamin D (25OHD) levels with aggressive treatment for those with levels &amp;lt;75 nmol/L (&amp;lt;30 ng/mL). More research is needed to determine optimal supplementation goals and strategies. PMID: 20148079 full text on-line&lt;/p></description></item></channel></rss>